AREC's ReElement Expands Advanced Rare Earth Laboratory Capacity

05.03.26 13:11 Uhr

American Resources Corporation AREC, through its portfolio company, ReElement Technologies Corporation, has expanded and commissioned advanced laboratory capabilities to further strengthen its rare earth and critical mineral refining platform.  The enhancement is designed to accelerate the commercialization of ultra-high-purity strategic materials serving defense, energy and advanced manufacturing markets. The upgraded laboratory builds upon ReElement’s proprietary chromatographic refining platform and recently filed next-generation patents. It integrates advanced analytical and characterization equipment to enhance precision and performance. New capabilities include an X-Ray Diffractometer (XRD) for rapid material identification, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for highly sensitive trace and isotopic analysis, ICP-Optical Emission Spectroscopy (ICP-OES) for multi-element quantification and a laser diffraction particle size analyzer to optimize processing and ensure quality compliance. These additions significantly strengthen ReElement’s precision testing and purity validation capabilities, particularly in verifying heavy rare-earth separation. The expanded lab supports commercial refining programs targeting ultra-high purity levels ranging from approximately 99.5% to 99.999% for critical elements such as gadolinium, gallium, germanium, terbium and yttrium. The enhanced infrastructure is also expected to streamline feedstock qualification and final product validation as the company scales its multi-feedstock processing platform. Shares of AREC have skyrocketed 432% over the past year compared with the industry’s 53.9% rise. Image Source: Zacks Investment ResearchAREC’s Zacks Rank & Key PicksAREC carries a Zacks Rank of #3 (Hold). Better-ranked stocks in the Basic Materials space include Nexa Resources S.A. NEXA, OR Royalties, Inc. OR and Wheaton Precious Metals Corp. WPM. NEXA, OR and WPM sport a Zacks Rank of #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for NEXA’s current-year earnings is pegged at $1.7 per share, indicating a 100% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average earnings surprise being 76%. The Zacks Consensus Estimate for OR’s current fiscal-year earnings stands at $1.43 per share, reflecting a 63% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average earnings surprise being 5%. The Zacks Consensus Estimate for WPM’s current fiscal-year earnings is pegged at $2.73 per share, indicating a 94% year-over-year decline. Its earnings beat the Zacks Consensus Estimate in all of the trailing four quarters, with the average earnings surprise being 6%. Quantum Computing Stocks Set To SoarArtificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.Access the Report Free Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report OR Royalties Inc. (OR): Free Stock Analysis Report Wheaton Precious Metals Corp. (WPM): Free Stock Analysis Report Nexa Resources S.A. (NEXA): Free Stock Analysis Report American Resources Corporation (AREC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Laboratory Corp. of America Holdings

Analysen zu Laboratory Corp. of America Holdings

DatumRatingAnalyst
21.06.2019Laboratory BuyDeutsche Bank AG
03.12.2018Laboratory HoldCraig Hallum
25.10.2018Laboratory HoldCanaccord Adams
26.02.2018Laboratory OverweightBarclays Capital
01.12.2017Laboratory BuyMizuho
DatumRatingAnalyst
21.06.2019Laboratory BuyDeutsche Bank AG
26.02.2018Laboratory OverweightBarclays Capital
01.12.2017Laboratory BuyMizuho
07.03.2017Laboratory OverweightBarclays Capital
18.01.2017Laboratory BuyDeutsche Bank AG
DatumRatingAnalyst
03.12.2018Laboratory HoldCraig Hallum
25.10.2018Laboratory HoldCanaccord Adams
17.02.2017Laboratory NeutralMizuho
06.02.2017Laboratory NeutralRobert W. Baird & Co. Incorporated
15.09.2016Laboratory NeutralMizuho
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Laboratory Corp. of America Holdings nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen